Endoscopic, ultrasound-guided, radiofrequency ablation of aldosterone-producing adenomas (FABULAS): a UK, multicentre, prospective, proof-of-concept trialGiulia Argentesi, Jessica Kearney, Sam O’Toole et al.|The Lancet|2025Cited by 25
A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[<sup>18</sup>F]Fluoroethyletomidate in Healthy Volunteers and Patients with Primary AldosteronismDaniel Gillett, Mark Gurnell, James MacFarlane et al.|Journal of Nuclear Medicine|2025Cited by 11
THU594 Outcome Data From Fabulas: A Feasibility Study Of Radiofrequency Endoscopic Ablation, With Ultrasound Guidance, As A Non-surgical, Adrenal Sparing Treatment For Aldosterone Producing AdenomasGiulia Argentesi, Morris J. Brown, Xilin Wu et al.|Journal of the Endocrine Society|2023Cited by 1
Endoscopic, ultrasound guided, radiofrequency ablation of aldosterone producing adenomas: A prospective, proof-of-concept trialMorris J. Brown, William M Drake, Giulia Argentesi et al.|Research Square|2024Cited by 0
Endoscopic, Ultrasound Guided, Radiofrequency Ablation of Aldosterone Producing Adenomas: A Prospective, Proof-of-Concept TrialGiulia Argentesi, Morris J. Brown, Xi‐Lin Wu et al.|SSRN Electronic Journal|2024Cited by 0